PIN90 COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM

May 1, 2020, 00:00
10.1016/j.jval.2020.04.553
https://www.valueinhealthjournal.com/article/S1098-3015(20)30741-5/fulltext
Title : PIN90 COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30741-5&doi=10.1016/j.jval.2020.04.553
First page :
Section Title :
Open access? : No
Section Order : 10435
Categories :
Tags :
Regions :
ViH Article Tags :